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Abstract
Rationale Reflection impulsivity-a failure to gather and evaluate information before making a decision-is a
critical component of risk-taking and substance use behaviours, which are highly prevalent during
adolescence. Objectives and methods The Information Sampling Test was used to assess reflection
impulsivity in 175 adolescents (mean age 18.3, range 16.5-20; 55% female)-48 cannabis users (2.3 years
use, 10.8 days/month), 65 alcohol users, and 62 non-substance-using controls-recruited from a
longitudinal cohort and from the general community and matched for education and IQ. Cannabis and
alcohol users were matched on levels of alcohol consumption. Results Cannabis users sampled to the
lowest degree of certainty before making a decision on the task. Group differences remained significant
after controlling for relevant substance use and clinical confounds (e.g., anxiety, depressive symptoms,
alcohol, and ecstasy use). Poor performance on multiple IST indices was associated with an earlier age
of onset of regular cannabis use and greater duration of exposure to cannabis, after controlling for recent
use. Alcohol users did not differ from controls on any IST measure. Conclusions Exposure to cannabis
during adolescence is associated with increased risky and impulsive decision making, with users
adopting strategies with higher levels of uncertainty and inefficient utilisation of information. The young
cannabis users did show sensitivity to losses, suggesting that greater impulsivity early in their drug using
career is more evident when there is a lack of negative consequences. This provides a window of
opportunity for intervention before the onset of cannabis dependence.
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Abstract
Rationale Reflection impulsivity – a failure to gather and evaluate information before
making a decision – is a critical component of risk-taking and substance use
behaviours, which are highly prevalent during adolescence.
Objectives and Methods The Information Sampling Test was used to assess reflection
impulsivity in 175 adolescents (mean age 18.3, range 16.5-20; 55% female) – 48
cannabis users (2.3 years use, 10.8 days/month), 65 alcohol users and 62 nonsubstance-using controls – recruited from a longitudinal cohort and from the general
community and matched for education and IQ. Cannabis and alcohol users were
matched on levels of alcohol consumption.
Results Cannabis users sampled to the lowest degree of certainty before making a
decision on the task. Group differences remained significant after controlling for
relevant substance use and clinical confounds (e.g., anxiety, depressive symptoms,
alcohol and ecstasy use). Poor performance on multiple IST indices was associated
with an earlier age of onset of regular cannabis use and greater duration of exposure to
cannabis, after controlling for recent use. Alcohol users did not differ from controls on
any IST measure.
Conclusions Exposure to cannabis during adolescence is associated with increased
risky and impulsive decision making, with users adopting strategies with higher levels
of uncertainty and inefficient utilisation of information. The young cannabis users did
show sensitivity to losses, suggesting that greater impulsivity early in their drug using
career is more evident when there is a lack of negative consequences. This provides a
window of opportunity for intervention before the onset of cannabis dependence.
Keywords: Cannabis; Alcohol; Adolescence; Reflection impulsivity; Decision
making
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Introduction

Impulsivity, risky decision making and deficits in inhibitory control are thought
to underlie addictive behaviours (Goldstein and Volkow 2002; Jentsch and Taylor
1999; Yücel et al. 2007) and play a critical role in the maintenance and relapse to
substance use (Garavan and Stout 2005). Adult long-term cannabis users have been
shown to exhibit deficits in various inhibitory processing measures (e.g., Stroop,
Go/NoGo) (Battisti et al. 2010; Bolla et al. 2002; Bolla et al. 2005; Eldreth et al.
2004; Gruber and Yurgelun-Todd 2005; Hester et al. 2009; Novaes et al. 2008;
Solowij et al. 2002; Tapert et al. 2007). Poorer performance has been associated with
parameters of cannabis use such as duration, dosage and age of onset of use (Battisti
et al. 2010; Bolla et al. 2002; Novaes et al. 2008; Solowij et al. 2002). Typically,
users show impairment in the ability to self-monitor behaviour, having low error
awareness (Hester et al. 2009) and increased error rates (Battisti et al. 2010). In some
studies where users have shown comparable performance to controls, this has been
accompanied by altered electrophysiology or increased activation of brain regions
indicating that users may require increased neural effort in order to maintain adequate
performance levels (Battisti et al. 2010; Hester et al. 2009; Tapert et al. 2007).
Cannabis-related deficits have been identified in a small number of studies that
used tasks specifically designed to measure risky or impulsive decision making, such
as the Matching Familiar Figures Task (MFFT) (Kagan 1966) or the Iowa Gambling
Task (IGT; Bechara et al. 1994) (e.g., Fridberg et al. 2010; Hermann et al. 2009;
Lamers et al. 2006; Wesley et al. 2011; Whitlow et al. 2004). Whitlow et al. (2004)
found that long-term heavy cannabis users made decisions that led to greater
immediate gains but with more costly losses than non-user controls. They suggested
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that the imbalance between perceived rewards and punishments may contribute to
ongoing drug use. Fridberg et al. (2010) enlarged the small sample of Whitlow et al.
(2004) and applied mathematical modeling to the data to show that cannabis users’
choices were characterized by greater sensitivity to gains, insensitivity to losses,
greater dependence upon recent outcomes, and less consistency with expected
payoffs. Differences between cannabis users and controls in motivational, learning
and memory, and behavioural control processes were thought to underlie their
characteristic performance on the IGT. In a recent imaging study, Wesley et al.
(2011) showed less activation in cannabis users relative to controls in regions
subserving complex decision making and a lack of correlation between performance
over time and functional response to losses, indicative of insensitivity to feedback
during strategy development in the users.
Impulsivity is a multi-factored concept comprising attentional, predecisional
reflection and disinhibition dimensions (Dickman 1993), and includes both motor and
cognitive factors (Evenden 1999a). The high demands on visual search, working
memory and strategy use of tasks such as the MFFT and the IGT may not be
capturing information specific to impulsive or risky decision making in cannabis
users, since the former processes are also known to be impaired in cannabis users
(Ilan et al. 2004; Jager et al. 2006; Kanayama et al. 2004; Solowij and Battisti 2008).
The cognitive construct of reflection impulsivity specifically refers to the tendency to
gather and evaluate information prior to decision making (Kagan 1966), which
contrasts with ‘the tendency to make an impulsive selection of a solution’ (Kagan
1965, p.609).

The Information Sampling Task (IST) from the Cambridge

Neuropsychological Test Automated Battery (CANTAB) was designed to specifically
measure reflection impulsivity and decision making (Clark et al. 2009), being deemed
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to be a purer measure than previous such tasks (e.g., the MFFT or the IGT). Rather
than relying on speed-accuracy indices, the IST measures reflection impulsivity by
calculating the probability of the subject selecting the correct answer at the point of
decision on the basis of their sampling of information prior to making that decision,
and the IST has a low working memory load.
Clark et al. (2009) were the first to examine reflection impulsivity by means of
the IST in current and former ecstasy users compared to young adult cannabis users
with no lifetime use of ecstasy and to non-drug-using controls. Despite the fact that
the primary aim of their study was to examine impulsivity in regular ecstasy users
(n=46), they found that the considerably smaller group of current cannabis users
(n=15) but not ecstasy users were impaired. The cannabis users sampled significantly
less information on the task and tolerated a lower level of certainty in their decision
making than did controls, while current and former ecstasy users did not differ from
controls. In an earlier study, Clark et al. (2006) reported that current amphetamine
and opiate users also sampled less information than controls and had a lower
probability of making a correct response on the task. Around half of the drug users in
the study were also using cannabis. As such, the IST may be particularly sensitive to
the effects of cannabis on information sampling and impulsive decision making.
No studies to date have examined reflection impulsivity in adolescent cannabis
users. Risky decision making and impulsivity are also characteristic of adolescence;
adolescents show the capability to reflect on risky decisions but often choose not to,
and this may underlie substance use and other risky behaviours (Steinberg 2007).
Adolescence is the primary period for experimentation and subsequent initiation of
regular cannabis use in particular (Copeland and Swift 2009; Jacobus et al. 2009).
There are concerns from both human and preclinical research that the adolescent brain
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may be especially vulnerable to the adverse effects of exposure to cannabis (Cha et al.
2006; Lubman et al. 2007; Schepis et al. 2008; Schneider 2008; Yücel et al. 2007). A
growing literature has reported a range of cognitive deficits in adolescent cannabis
users and greater adverse effects the earlier that cannabis use commences, particularly
before the age of 17 years (Ehrenreich et al. 1999; Harvey et al. 2007; Huestegge et al.
2002; Jacobsen et al. 2004; Jacobsen et al. 2007; Jacobus et al. 2009; Kempel et al.
2003; Medina et al. 2007; Pope et al. 2003; Schwartz et al. 1989; Solowij and Battisti
2008; Solowij et al. 2011).
In this study, we examined the IST performance of adolescent cannabis users in
relation to parameters of cannabis use such as quantity, frequency, duration and age of
onset of use. Since adolescent cannabis users often also drink alcohol (Copeland and
Swift 2009), and tend to consume more alcohol than non-users (Chun et al. 2010), we
also sought to determine the specificity of effects by comparing the cannabis group
with an adolescent alcohol user group matched on monthly alcohol use, as well as
with a non-user control group.

Finally, we had the opportunity to control for

premorbid intellectual ability (obtained at entry to high school) and to examine its
potential influence on reflection impulsivity and risky decision making.

Methods

Subjects
A total of 175 adolescent participants (mean age 18.3, SD=0.63) were recruited
for this study, comprising 48 cannabis users, 65 alcohol users and 62 controls. The
majority of participants were recruited from the Wollongong Youth Study (WYS) – a
longitudinal study of adolescents followed since entry to six metropolitan and
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regional high schools in the wider southern Sydney region of Australia (Heaven and
Ciarrochi 2008). Due to the small sample size of cannabis users recruited from this
source (n=12), a newspaper advertisement was used to recruit an additional 36
adolescent cannabis users to the study from the same demographic catchment as the
WYS participants. Externally recruited participants were matched on age, IQ and
premorbid intellectual ability to the WYS sample. They did not differ from the WYS
cannabis or alcohol users on monthly alcohol consumption and a range of
psychological factors as described below, but they were more entrenched in their
cannabis use (greater frequency (p<0.001) and quantity (p<0.001) of cannabis use per
month). Full details of the sample are provided in Solowij et al. (2011).
The study was fully approved by the University of Wollongong and South
East Sydney and Illawarra Area Health Service Human Research Ethics Committee
and conducted in accordance with the Declaration of Helsinki. Participants provided
written informed consent and were reimbursed AU$50 for their time and travel
expenses.

Measures of psychological functioning and intellectual ability
Subjects were screened for potential psychological disorders using the Kessler
Psychological Distress Scale K10 (Kessler et al. 2002) and structured interview
assessed psychiatric, medical and neurological history. Participants were excluded for
any current psychiatric disorders, if they were currently in treatment for substance
dependence, and if they had any history of head injury or serious medical conditions.
Participants completed the State-Trait Anxiety Inventory (STAI; Spielberger
1989), the Beck Depression Inventory (BDI; Beck et al. 1996) and the Apathy
Evaluation Scale (AES; Marin et al. 1991) as measures of psychological well-being or
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symptoms. All participants completed the short form of the Wechsler Abbreviated
Scale of Intelligence (WASI) to obtain a measure of current IQ.

Measures of

premorbid intellectual ability were available for the majority of the sample (66.3%: 24
cannabis users, 47 alcohol users, 45 controls) from standardised verbal and numerical
ability tests administered by the Department of Education to all students during their
first year of high school (at approximately age 12).

Substance use characteristics of the sample
Current and past substance use was assessed by structured interview that
incorporated the Alcohol Use Disorders Identification Test (AUDIT; Allen et al.
1997) and a TimeLine Follow Back procedure (TLFB; Sobell and Sobell 1992).
Average frequency and quantity of cannabis and alcohol consumed per month were
calculated from across these measures. TLFB data informed of any other drug use in
the past 30 days. Cannabis users were also administered the Marijuana Withdrawal
Checklist (MWC; adapted from Budney et al. 1999 and Vandrey et al. 2005) and the
Severity of Dependence Scale (SDS; Swift et al. 1998) for cannabis.
Cannabis and alcohol users were required to have used cannabis or alcohol at
least twice/month for 6-12 months. The majority were regular users (Table 2) but
several participants were included in their respective samples despite a briefer period
of exposure to either substance if use in recent months had been particularly frequent
or heavy, or if they had less frequent use that had nevertheless been ongoing for >18
months. This policy was applied to be inclusive as possible for participants with
available data and since such users would not qualify as non-user controls. Similarly,
participants were included in the control group if they reported ‘regular’ alcohol use
that was less than twice/month and may have engaged in such low level drinking for
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more than 12 months (or if they drank at least twice/month but had only commenced
doing so in the past 2 months, in which case they would not qualify for the alcohol
user group). Some participants in the alcohol and control groups had tried cannabis in
their lifetime (29.2% of alcohol users and 8.1% of controls; maximum five
occasions).
All participants were asked not to consume cannabis, alcohol or any other
illicit substances for at least 12 hours before testing and self-reported abstinence was
supported by breath analysis (zero alcohol readings for the entire sample), urinalysis
(for all illicit drugs) and saliva testing for delta-9-tetrahydrocannabinol (THC) using
gas chromatography-mass spectrometry (Cozart Bioscience Ltd 2001-2009).
Cannabis users reported a median 22.5 hours abstinence from cannabis. The median
carboxy-THC metabolite in urine for the cannabis using sample was 84ug/L [0-4335].
No cannabinoid metabolites were detected in controls or alcohol users. The median
THC level in saliva in cannabis users was 0ng/ml [0-7.2]. THC may remain in the
oral cavity for 24 hours or more after smoking with levels generally falling below
1ng/ml 12-24 hours after smoking (Huestis and Cone 2004; Niedbala et al. 2001) but
with much individual variability. Salivary THC levels were below 1ng/ml in the vast
majority of the current sample (82.6%; 54.3% had zero levels) and strong correlations
between salivary THC or urinary cannabinoid levels and self-reported hours since last
use (Spearman’s rho=-0.55, p<0.001 and rho=-0.70, p<0.001, respectively) provide
good corroboration with self-reported abstinence from cannabis prior to testing.

The Information Sampling Task (IST)
Participants first completed a single practice trial, followed by 10 trials in each
of the two conditions of the IST. On each trial they were presented with a 5 x 5
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matrix of grey boxes with two larger coloured panels at the foot of the screen.
Touching a grey box would immediately open that box to reveal one of the two
colours displayed at the bottom of the screen. Subjects were able to open boxes at
their own rate with no time limit before deciding which of the two colours was in the
majority of the 25 boxes.

According to manualised instructions and procedures

described in Clark et al. (2006), they were told ‘it is entirely up to you how many
boxes you open before making your decision’ and they indicated their decision by
touching one of the two panels at the bottom of the screen.

At this point the

remaining boxes were uncovered and one of two messages was presented: “Correct!
You have won [x] points” or “Wrong! You have lost 100 points”. In the ‘fixed win’
condition subjects could open any number of boxes to potentially gain 100 points and
not lose any points. In the ‘decreasing win’ condition, subjects lost 10 points for
every box that they opened. There was a variable delay of at least 1 second before the
onset of the next trial.
The primary performance outcome measures were the mean number of boxes
opened per trial, the mean probability of being correct at the point of decision:
P(Correct), and discrimination and sampling errors. P(Correct) was the probability
that the colour chosen by the subject at the point of decision would be correct, based
only on the evidence available to the subject at the time (i.e., dependent on the amount
of information they had sampled).

Discrimination errors occurred when the

participant chose a colour that was not at that point in time in the majority, thus
making a decision not logically based on the evidence available to them. Sampling
errors were the number of trials where the subject chose a colour that was not in the
overall majority but was in the majority at the point of decision. Mean box opening
latency was also measured (the time elapsed between the subject opening a box and
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then opening the subsequent box), as was mean colour decision latency (the time
elapsed between the start of a trial and the point at which the subject selects a colour
that they believe to be in the overall majority).

Statistical Analysis
Data were analysed using SPSS version 16 using repeated measures (condition:
Fixed vs Decreasing win x group) analysis of variance (rmANOVA) with follow up
Tukey tests for group comparison on normally distributed variables. Analysis of
covariance (ANCOVA) was then conducted for normally distributed variables. For
variables that violated the Shapiro-Wilk test of normality, non-parametric MannWhitney and Kruskal-Wallis follow up tests were employed examining fixed and
decreasing win conditions separately.

Pearson correlations were performed for

normally distributed variables and Spearman correlations for skewed variables to
examine relationships between performance and substance use and clinical variables.

Results

Demographics and Patterns of Substance Use
Demographic and clinical characteristics of the sample are shown in Table 1.
The three groups did not differ in current full scale IQ (F(2,174)=0.07, p=0.93) or
premorbid verbal (F(2,116)=1.46, p=0.24) or numerical ability (F(2,115)=2.58,
p=0.08). While the groups differed significantly in age (F(2,174)=11.47, p<0.001),
this was due to the precision with which we measured age (in portions of months).
The mean age at assessment in each group was 18 years (Table 1) and, while minor
variation in portions of months would not be expected to influence performance

12
outcome measures, we nevertheless included age as a covariate in our between-group
analyses. The gender ratio differed between groups (χ2(2)=10.24, p=0.006) with
females overrepresented in the control group. Group differences were observed on
apathy scores (χ2(2)=14.80, p=0.001; cannabis users > alcohol users and controls),
depressive symptoms (χ2(2)=10.43, p=0.005; cannabis users > controls) and state
anxiety (χ2(2)=10.24, p=0.006; controls < cannabis users and alcohol users), but not
trait anxiety (p=0.08).

Variables on which groups differed were included as

covariates in the analyses.
Table 2 shows the substance use characteristics of the sample. The cannabis
users first tried cannabis around age 15, with regular use commencing around age
16.5. They had used cannabis regularly for a mean 2.3 years and were currently using
approximately 10 days per month. After self-reported abstinence from cannabis for a
median 22.5 h, the cannabis users reported a median score of 5 on the withdrawal
scale from a possible 45-point maximum, indicating that withdrawal symptoms were
of minor concern to participants during testing. The median score on the SDS
suggests that this young sample were not yet dependent on cannabis. Cannabis users
did not differ from alcohol users in frequency or quantity of alcohol consumed per
month, but cannabis users had started drinking at an earlier age and had higher
AUDIT scores. Cannabis users smoked more tobacco cigarettes per day than either
other group and alcohol users also smoked more than controls. Cannabis users had
used other illicit substances on more occasions than any other group but had never
used these on a regular basis. Thirteen cannabis users (27%) had used ecstasy in the
past 30 days (0-3 pills consumed). One alcohol user had consumed two ecstasy
tablets in the past 30 days. Other recent drug use in the cannabis group was modest
with 2 having used amphetamines, 1 having used cocaine and 2 having consumed
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hallucinogenic mushrooms in the past 30 days. Cannabis users with and without
recent other drug use were compared on their IST performance.

Tables 1 and 2 about here

IST Performance: P(Correct) and Number of Boxes Opened
Analyses revealed a significant main effect of group for the probability of being
correct at the point of decision (F(2,172)=6.02, p=0.003) and for the number of boxes
opened per trial (F(2,172)=4.32, p=0.015), with cannabis users having a significantly
lower P(Correct) score than both alcohol users (p=0.008) and controls (p=0.006),
while the latter groups did not differ (p=0.99). Cannabis users opened fewer boxes
than alcohol users (p=0.012) but not controls (p=0.11), and the latter groups did not
differ (p=0.63). Table 3 shows P(Correct) and number of boxes opened for both fixed
and decreasing win conditions. In the fixed win condition, cannabis users sampled
information to a point of 79% certainty while alcohol users and controls sampled to a
point of 85% certainty. This reduced for all groups in the decreasing win condition,
with cannabis users sampling to a point of 68% certainty and alcohol users and
controls 71% and 72%, respectively. While there was a significant main effect of
condition (F(1,172)=302.77, p<0.001), there was no significant condition by group
interaction (p=0.24), with similar results for the number of boxes opened (main effect
of condition: (F(1,172)= 354.08, p<0.001); condition by group interaction: p=0.57).

Figure 1 and Table 3 about here

We next used covariate analyses to control for variables that differed between
groups. The main effect of group remained significant for P(Correct) after controlling
for gender (F(2,171)=5.72, p=0.004), age (F(2,171)=7.07, p=0.001), AUDIT score
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(F(2,170)=6.06, p=0.003), hours since last consumption of alcohol (F(2,159)=4.90,
p=0.009), age of first alcohol use (F(2,163)=5.02, p=0.008), cigarettes smoked per
day (F(2,165)=3.31, p=0.03), apathy (F(2,171)=4.48, p=0.013), depressive symptoms
(F(2,171)=5.23, p=0.006) and state anxiety (F(2,169)=7.28, p=0.001).

With all

covariates in the model the main effect of group was F(2,146)=4.97, p=0.008, and
apathy was the only significant covariate in the model (p=0.012). Including age of
onset of regular alcohol use as a covariate however, reduced the significance of the
overall group difference for P(Correct) (F(2,143)=2.98, p=0.054). The ages of onset
of regular use of cannabis and of alcohol were highly correlated (Spearmans’
rho=0.49, p<0.001) and we show below that the effects observed on performance
were associated with cannabis use and not with alcohol use. The same pattern of
results was evident for the number of boxes opened when the above covariates were
included in the model.

IST Performance: Errors
Table 3 shows that cannabis users’ task accuracy was impaired specifically in
the fixed win condition, with more discrimination errors (χ2(2)=9.39, p=0.009) than
alcohol users (Z=2.04, p<0.05) and controls (Z=3.04, p<0.01). There were trends
toward cannabis users making more discrimination errors in the decreasing win
condition also (p=0.09), and toward more sampling errors in the fixed win condition
(p=0.09).

IST Performance: Latency measures
As shown in Table 3, there were no significant differences between the three
groups for mean box opening latency in either condition. Colour decision latency was
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significantly different between the groups in the fixed condition only (χ2(2)=6.06,
p=0.048), with cannabis users making faster colour decisions than both controls
(Z=2.31, p<0.05) and alcohol users (Z=2.02, p<0.05).

IST Performance Associations with Cannabis Use and Psychological Measures
Correlations between primary substance use measures and IST performance
measures are shown in Table 4.

The majority of associations between IST

performance and cannabis use measures were found for age of onset and duration of
cannabis use in the fixed win condition. Earlier onset of first or regular use of
cannabis was associated with lower P(Correct), fewer boxes opened, and more
sampling errors in the fixed win condition. An earlier age of onset of regular use was
also associated with more discrimination errors and longer box opening latency in the
fixed win condition. A longer duration of regular use of cannabis was associated with
lower P(Correct) scores, fewer boxes opened, more sampling errors, more
discrimination errors and longer box opening latency in the fixed condition alone.

Table 4 about here
Greater frequency cannabis use was also associated with a lower probability of
being correct at point of decision P(Correct) in the fixed condition alone, and greater
frequency and quantity of cannabis use per month were positively correlated with
discrimination errors in both fixed and decreasing win conditions. Therefore, the
more frequent and heavy the cannabis use, the more likely the subject was to choose a
colour that was not in the majority at point of decision. Greater quantity cannabis use
was also significantly correlated with a longer box opening latency in the fixed
condition. Salivary THC levels correlated with only one IST measure: discrimination
errors in the fixed win condition, which also correlated with self-reported hours since
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last use, and the only other measure to correlate with self-reported hours since last use
was the mean colour decision latency in the decreasing win condition (rho=-0.49,
p=0.005). Urinary cannabinoid metabolite levels correlated inversely with P(correct),
and positively with discrimination errors and box opening latency, all in the fixed win
condition, and additionally with discrimination errors in the decreasing win condition.
These results suggest that recent cannabis use and residues may also exert an
influence on reflection impulsivity and decision making.
No IST measures were associated with cannabis dependence or withdrawal
scores, depressive symptom scores, state or trait anxiety, apathy or AUDIT scores (all
p>.05).

Current frequency or quantity of alcohol consumption were also not

associated with any of the IST measures. However, a later age of onset of first (but
not regular) alcohol use in the cannabis group was associated with a greater number of
boxes opened in the fixed win condition and fewer sampling errors in the decreasing
win condition. Age of onset of regular alcohol use in the cannabis group was not
associated with any IST performance measures.

Partial Correlations between various Cannabis Measures
Partial correlations were performed between various cannabis use measures to
determine their relative effects on IST performance, concentrating on the primary
outcome measure of P(Correct).

As shown in Table 5, the association between

P(Correct) and age of onset of cannabis use and duration of cannabis use remained
significant after controlling for measures of recent cannabis use (self-reported hours
since last use, salivary and urinary cannabinoids). This suggests a greater influence
on performance of longer duration cannabis use commencing at an early age, rather
than residual effects of recent cannabis use. There were no significant associations
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between hours since last use, salivary or urinary cannabinoids and P(Correct) after
controlling for age of onset and duration of cannabis use. Further, a specific effect of
early onset and long duration cannabis use over and above recent use was determined
by showing that their association with P(Correct) remained after controlling for
current levels of exposure to cannabis (quantity and frequency per month), but not the
reverse (i.e., no associations between current quantity and frequency of cannabis use
remained with P(Correct) after controlling for age of onset and duration of use).

Table 5 about here
Recent Other Drug Use
Within the cannabis group, 27% of participants had used ecstasy in the past 30
days, as had one of the alcohol users. The number of pills consumed in the past 30
days was used as a covariate in the analysis. The main effect of group for P(Correct)
(F(2,171)=6.94, p=0.001) and for number of boxes opened (F(2,171)=5.49, p=0.005)
remained significant with the poorest performance in cannabis users compared to both
alcohol users (p<0.01) and controls (p<0.05), after controlling for ecstasy use.
Cannabis users who had consumed other drugs (including ecstasy,
amphetamine, cocaine and hallucinogenic mushrooms) in the past 30 days (n=13)
were then compared to those cannabis users who had not used any other drugs aside
from cannabis and alcohol in the past 30 days (n=35). There were no differences
between the two groups for P(Correct) (F(1,46)=0.48, p=0.49) or number of boxes
opened (F(1,46)=0.002, p=0.96), and no differences between groups on any other IST
measure (all p>0.28). Therefore, other recent drug use did not affect IST performance
within the cannabis group, suggesting impaired performance specific to cannabis use.

Discussion
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The results of this study demonstrate impairment in the ability to gather and
evaluate information prior to decision making in a sample of adolescent cannabis
users. These young cannabis users were impaired on most IST performance outcome
measures and our findings suggest greater impairment following early initiation and
prolonged exposure to cannabis use over and above recent exposure.

We

demonstrated a specific association with cannabis rather than alcohol or other
concomitant drug use.
The adolescent cannabis users sampled to a lower probability of certainty, made
faster (more impulsive) decisions, and made more discrimination errors. The majority
of these deficits remained significant after controlling for recent ecstasy use, alcoholrelated problems, tobacco use, apathy and psychological symptoms (depression and
state anxiety), and age and gender differences between groups.

These findings

suggest poor reflection and decision making at a lower level of certainty in adolescent
cannabis users relative to adolescent alcohol users and non-substance-using controls.
The majority of IST performance outcome measures worsened with an earlier
age of onset of cannabis use and longer duration of use. The earlier that these young
users initiated regular cannabis use and the longer the term of their exposure, the more
likely they were to open fewer boxes, have faster box opening latencies, and have a
lower probability of being correct at the point of decision. Greater sampling and
discrimination errors were also associated with an earlier age of onset of use and
longer exposure to cannabis. This was particularly evident in the fixed win condition.
Greater frequency and quantity of cannabis use per month were associated with
more discrimination errors, and frequency was also associated with lower P(correct).
Thus, current frequent and heavy use of cannabis led to decision making that was not
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logically based on the evidence available. This might suggest that impaired decision
making is related to current use of cannabis, but partial correlational analyses revealed
a specific effect of earlier age of onset and duration of use on IST performance after
controlling for current use, and not the reverse. No significant associations between
IST performance and current cannabis use remained after controlling for age of onset
and duration of cannabis use. Further, impaired performance could not be attributed
to acute intoxication or withdrawal symptoms – 54.3% of the cannabis sample had
zero THC levels detected in saliva and a further 28.3% had levels less than 1ng/ml,
and no performance measures correlated with withdrawal scores.
As the IST puts minimal demands on working memory (Clark et al. 2006), these
findings do not reflect a simple deficit in working memory in the young cannabis
users of this study. Despite a lack of condition by group interactions, the majority of
significant associations with cannabis use measures were in the fixed win condition,
where there were no losses contingent upon performance.

The introduction of

negative reinforcement (i.e., losing points in the decreasing win condition) may
override some of the effects of cannabis on impulsive tendencies and adolescent
cannabis users may need more motivation to self-regulate these. Our findings of
impaired reflection impulsivity in adolescent cannabis users, with perhaps greater
effects in the fixed win condition, are similar to those reported by Clark et al. (2009)
in a sample of young adult cannabis users, as well as in opiate and amphetamine users
(Clark et al. 2006). However, this study did find that the implementation of a loss
condition modified adolescent cannabis users’ risky behaviour. This is in contrast to
Fridberg et al. (2010) who found that adult cannabis users were less sensitive to loss
on the IGT than controls and were also more motivated by immediate reward.
Fridberg et al’s sample were chronic adult cannabis users who had been using for an
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average of 13 years, while our relatively novice sample had been using regularly for
just over 2 years. Therefore, it may be that at a relatively young stage of cannabis use
without the development of dependence, adolescents may respond to loss with
reductions in impulsive behaviour. However, if cannabis use is continued over time
and with the development of dependence, they may be less likely to respond to these
cues and will show more consistently risky and impulsive behaviour, regardless of
consequence. If the tendency toward risky decision making could be modified at an
early stage, then this may have benefits for future outcomes not only in a cognitive
domain but also for future risky and impulsive behaviour such as unsafe sex,
experimentation with other drugs and heavy drinking.
The current sample of adolescent users commenced cannabis use between the
ages of 15 and 16 years. This is a period characterised by neurodevelopmental
changes where the brain is undergoing significant resculpting, synaptic pruning and
ongoing myelination (Paus 2005; Schepis et al. 2008; Schneider 2008).

The

prefrontal cortex together with its connections with the amygdala and striatum have
been implicated in the neurocircuitry of cognitive and affective decision making
(Clark et al. 2004; Ernst and Paulus 2005; Krain et al. 2006). Recent neuroimaging
studies have demonstrated structural alterations (Lorenzetti et al. 2010; Yücel et al.
2008; Yücel et al. 2010) and altered activation patterns (Nestor et al. 2010; Wesley et
al. 2011) in these brain regions in long-term cannabis users. Further investigation into
the mechanisms that may potentially underlie the current findings is warranted to
determine the impact of cannabis on the developing adolescent brain.

That the

adolescent brain may be more vulnerable to cannabis insult was highlighted in our
introduction.

We have reported greater adverse effects on verbal learning and

memory in this same sample (Solowij et al. 2011).

The current study provides
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evidence for greater adverse effects of cannabis on reflection impulsivity in
adolescence, in that our results from a young sample with relatively few years and less
monthly exposure to cannabis (approximately 17 joints per month) are comparable to
those of Clark et al’s (2009) study of young adults using 31.3 joints per month.
Poorer reflection impulsivity in cannabis-using adolescents might also be
subserved by an altered serotonergic system.

The serotonergic system has been

implicated in the regulation of impulse control, behavioural inhibition and effective
decision-making (Evenden 1999b; Clark et al. 2004; Soubrié 1986), with reductions
in serotonin (5-hydroxytryptamine, 5-HT) levels being associated with reduced
inhibitory control and increases in impulsive behaviour (Clark et al. 2009; Evenden
1999b). Cannabinoids have been shown to interact with 5-HT receptors (Kelaï et al.
2006; Kimura et al. 1998) and evidence from preclinical studies suggests the
involvement of cannabinoid receptors (CB1) in the regulation of serotonergic
responses (Lau and Schloss 2008; Mato et al. 2007), whereby stimulation of CB1
receptors reduces (Balazsa et al. 2008) and inhibits (Best and Regehr 2008; Nakazi et
al. 2000) 5-HT release. Administration of THC has been shown to decrease
serotonergic activity in various brain regions in animal studies (Molina-Holgado et al.
1993; Moranta et al. 2004; Sagredo et al. 2006). Chronic exposure to cannabinoids
during adolescence has similarly been shown to attenuate serotonergic activity
(Bambico et al. 2010) and differentially affect 5-HT1A receptor binding and mRNA
expression in adult versus adolescent brains (Zavitsanou et al. 2009).
The limitations of our study include the lack of available promorbid ability
scores for a portion of the sample, the recruitment of the larger portion of the sample
of adolescent cannabis users from outside of the longitudinal cohort from which
alcohol users and controls were recruited and the overrepresentation of females within
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the control group. We accounted for the majority of these limitations, as well as
differences between groups in other substance use, in the analyses conducted and do
not believe that they impact upon our results in any substantial way. While the small
sample size for those consuming other drugs in the past 30 days may render those
analyses underpowered to detect a difference between groups, the level of recent (and
indeed) other drug use was in any case low in the sample (Table 2).

Our

interpretations of the findings would, however, have been aided by pre-cannabis
exposure measures of impulsivity and decision-making. For example, it is possible,
that the cannabis users were more impulsive than the non-cannabis using groups prior
to cannabis exposure. Such pre-existing intrinsic impulsivity may have resulted in
both the ultimate use of cannabis, as well as an earlier initiation of cannabis use.
Therefore, caution should be taken when interpreting these findings in direct
association with cannabis exposure per se. A further limitation may be that the IST
was the final test in a battery of cognitive tasks administered in the same order to all
groups and lasting approximately one hour. It is possible that sustained vigilance may
be worse in cannabis users than in alcohol users and controls, which could lead to
greater fatigue effects in this group when performing the IST. Effects of fatigue,
effort and motivation in cannabis users could be further explored in relation to
reflection impulsivity, and particularly within tasks that include actual rewards and
punishment (e.g., monetary gains and losses). Further research could examine the
trajectory and nature of impulsive behaviours in the context of losses as cannabis
dependence develops, and determine the impact of ongoing cannabis use or cessation
of use in the context of the maturing adolescent brain.
In conclusion, regular adolescent cannabis users show deficits in reflecting on
responses prior to making a decision.

Impulsive decision making in this group
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appears to be associated more with cannabis use when there are no negative
consequences, but is impaired in conditions both with and without negative
consequences. Poor reflection impulsivity was associated with greater exposure to
cannabis and a younger age of onset, after controlling for both current and recent
cannabis use, and was not associated with alcohol use during adolescence nor
exposure to other drugs. Our findings have implications for the development of
interventions aimed at reducing impulsive and risky behaviour among young cannabis
users before the development of cannabis dependence.
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Table 1. Demographic and clinical characteristics of the sample: mean (SD) or median [range]
Alcohol Users
n=65
34/31

Controls
n=62
18/44

p (three-group comparison)

p (Cann vs. Alc)

Gender (M/F)

Cannabis Users
n=48
27/21

<0.01

0.68

Age

18.6 (0.8)

18.3 (0.5)

18.1 (0.5)

<0.001

<0.01

IQa

103.9 (14.2)

104.7 (12.2)

104.6 (10.3)

0.93

0.93

Premorbid verbal ability

90.1 (6.5)

92.4 (5.7)

91.3 (5.2)

0.24

0.22

Premorbid numerical ability

86.5 (7.3)

89.8 (6.5)

87.0 (7.3)

0.08

0.14

State anxiety

32.5 [23-54]

30 [20-56]

27.5 [20-45]

<0.01

0.98

Trait anxiety

39.2 (9.5)

36.5 (9.0)

34.9 (9.0)

0.06

0.28

Apathy Evaluation Scale

11 [2-29]

8 [0-31]

7 [0-31]

<0.001

<0.01

Beck Depression Inventory

6 [0-34]

4 [0-32]

3 [0-23]

<0.01

0.08

Kessler Psychological Distress

17.9 (4.7)

17.2 (4.3)

16.3 (4.2)

0.15

0.63

a

From WASI short version; Premorbid verbal ability scores available for 24 cannabis users, 48 alcohol users, 45 controls; Premorbid numerical ability scores
available for 24 cannabis users, 47 alcohol users, 45 controls.
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Table 2. Substance use characteristics of the sample: mean (SD) or median [range]
Cannabis Users

Alcohol Users

Controls

p (Cann vs. Alc)

Age of First Cannabis Use

15 [9-18]

17 [15-18.8]a

16 [14-17]a

<0.001

Age of Regular Cannabis Use

16.5 [12.5-18.8]

-

-

-

Duration of Regular Cannabis Use (years)

2.3 (1.2)

-

-

-

Frequency of Cannabis Use (days/month)

10.8 [0.5-30]

0

0

-

Quantity of Cannabis Use (cones/month)b

50 [3.5-1517.5]

0

0

-

Last Use of Cannabis (hours ago)

22.5 [12-2760]

-

-

-

Urinary THC-COOH (ng/mg)

84 [0-4335]

0

0

-

Salivary THC (ng/ml)

0 [0-7.2]

0

0

-

Severity of Dependence (cannabis)

2 [0-14]

-

-

-

Age of First Alcohol Use

15 [10-17]

15.5 [7-18]

16 [10-18]

<0.01

Age of Regular Alcohol Use

16 [12-18]

17 [14-18.5]

-

<0.001

Duration of Regular Alcohol Use (years)

2.5 [0.4-6.6]

1.3 [0.1-4.2]

-

<0.001

35

a

Frequency of Alcohol Use (days/month)

4 [0-12.5]

5 [2-12.33]

1.5 [0-4]

0.13

Quantity of Alcohol (std drinks/month)

35.6 [0-155]

27.6 [9.23-241.7]

3.2 [0-17.7]

0.63

Last Use of Alcohol (hours ago)

125 [17-3240]

84 [10-768]

134 [0-2880]

<0.05

AUDIT Total Score

12 [0-26]

9 [3-27]

2 [0-11]

<0.05

Cigarettes per day

1 [0-12.5]

0 [0-8.6]

0 [0]

<0.001

Lifetime Occasions of Illicit Substance usec

4 [0-123]

0 [0-8]

0 [0-1]

<0.001

19 of the alcohol users had tried cannabis, 5 controls had tried cannabis
Approximately 16.7 joints per month
c
Total number of occasions of use of illicit drugs over the lifetime excluding cannabis: drugs used included ecstasy, amphetamines, cocaine and
hallucinogenic mushrooms
b
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Table 3. Group differences on IST measures of reflection impulsivity: mean (SD) or median [range]; 3 group comparison and subgroup comparisons
Cannabis Users

P(Correct) FW
0.79 (0.11)
P(Correct) DW
0.68 (0.07)
Boxes opened per trial FW
14.32 (5.79)
Boxes opened per trial DW
7.65 (3.16)
Discrimination errors FW
1 [0-5]
Discrimination errors DW
1 [0-6]
Box opening latency FW ms
583 [237-1194]
Box opening latency DW ms
1139 [360-2594]
Colour decision latency FW s
10700 [3761-19564]
Colour decision latency DW s
9293 [4045-15893]
FW Fixed win condition; DW Decreasing win condition

Alcohol Users

Controls

0.85 (0.11)
0.71 (0.09)
17.02 (5.54)
9.36 (4.07)
0 [0-3]
1 [0-5]
568 [229-2650]
878 [226-2428]
11946 [5030-35341]
9131 [3361-35873]

0.85 (0.10)
0.72 (0.07)
16.06 (5.34)
9.02 (3.64)
0 [0-2]
0 [0-3]
655 [265-2001]
1021 [527-2604]
11291 [4980-35343]
9499 [3879-34535]

p
(threegroup
compari
son)
<0.01
<0.05
<0.05
<0.05
<0.01
0.20
0.37
0.07
<0.05
0.53

p (Cann p (Cann
vs. Con) vs, Alc)

p (Alc
vs. Con)

<0.01
<0.05
0.23
0.13
<0.01
0.09
0.46
0.31
<0.05
0.29

1.00
0.97
0.60
0.86
0.31
0.22
0.16
0.12
0.78
0.47

<0.01
0.07
<0.05
<0.05
<0.05
0.52
0.63
<0.05
<0.05
0.57
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Table 4. Correlations between IST performance measures and substance use in the cannabis user group: Pearson r or Spearman rho

Age first can
use
Age regular
can use
Duration
regular use
Cannabis
frequency
Cannabis
quantity
Hours since
last use
Salivary THC
Urinary
cannabinoids
Cannabis
dependence
Cannabis
withdrawal
Age first alc
use
Age regular
alc use
Alcohol

No. boxes
opened
DW
.16

Sampling
errors FW

Sampling
errors DW

Discrimination
errors FW

Discrimination
errors DW

.22

No. boxes
opened
FW
.33*

-.35*

-.12

-.26

-.21

Box
opening
latency FW
-.25

.42**

.13

.37*

.09

-.32*

-.23

-.42**

-.12

-.38**

-.46**

-.17

-.38*

-.14

.31*

.04

.48**

.27

.39**

-.30*

-.14

-.20

.01

.02

-.09

.36*

.42**

.26

-.23

-.15

-.08

.11

.11

-.09

.43**

.44**

.30*

.02

-.09

-.08

-.14

.16

.10

-.35*

-.20

-.21

-.10
-.37**

.21
-.23

.22
-.25

.23
-.07

-.40
.19

-.26
-.02

.56••
.36*

-.06
.45**

.02
.41**

-.03

.01

.02

.05

.04

.06

.18

.19

.11

-.17

-.02

-.15

.10

.17

-.06

.22

.13

.15

.25

.13

.32*

.20

-.29

-.31*

-.16

.15

-.18

.13

-.04

.15

.02

-.20

.03

-.19

-.01

-.04

.03

-.06

.10

-.05

.06

.01

-.15

-.21

-.07

P(Correct)
FW

P(Correct)
DW

.39**
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frequency
Alcohol
-.04
-.21
.04
-.15
.10
.03
quantity
FW Fixed win condition; DW Decreasing win condition; * p<0.05; **p<0.01

-.14

-.07

-.01
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Table 5. Partial correlations between cannabis use measures and IST performance (P(Correct) collapsed across FW and DW conditions): partial
r.
P(Correct)
Controlling for recent cannabis use and cannabinoid levels

a

Age of first cannabis use
Age of regular cannabis use
Duration of regular cannabis use
Cannabis frequency
Cannabis quantity

0.44**
0.30*
-0.35*
-0.23
-0.11

Hours since last use
Urinary cannabinoid level
Salivary THC level
Cannabis frequency
Cannabis quantity

-0.07
-0.17
-0.02
-0.09
-0.09

Age of first cannabis use
Age of regular cannabis use
Duration of regular cannabis use

0.37**
0.25*
-0.27*

Controlling for age of onset and duration of regular use

Controlling for frequency and quantity of cannabis use

FW Fixed win condition; DW Decreasing win condition
Recent cannabis use as self-reported hours since last use, cannabinoid metabolite levels in urine and salivary THC
* p<0.05; ** p<0.005

a
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Figure Captions

Fig. 1 Mean probability of being correct at the point of decision (P(correct)) in fixed
win and decreasing win conditions for adolescent cannabis users, alcohol users and
controls.
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